Abstract
Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have